Apellis Pharmaceuticals Downside Variance
| APLS Stock | | | USD 18.87 -0.07 -0.37% |
Reference data associated with the Downside Variance technical indicator for Apellis Pharmaceuticals. Technical inputs may vary across markets and data providers.
Apellis Pharmaceuticals has current Downside Variance of 0. Downside Variance (or DV) is measured by target semi-variance and is termed downside volatility. It is expressed in percentages and therefore allows for rankings in the same way as variance. One way to view downside volatility is the annualized variance of returns below the target.
Downside Variance | = | SUM(RET DEV)2N(ER) |
| = | 0 | |
| SUM | = | Summation notation |
| RET DEV | = | Actual returns deviation over selected period |
| N(ER) | = | Number of points with returns less than expected return for the period |
Downside Variance Peers Comparison
Downside Variance Relative To Other Indicators
Apellis Pharmaceuticals is rated
below average in downside variance relative to competitors. It is currently under evaluation in maximum drawdown relative to competitors .
Downside Variance is the probability-weighted squared below-target returns. The squaring of the below-target returns has the effect of penalizing failures at an exponential rate. This is consistent with observations made on the behavior of individual decision-making under.
Compare Apellis Pharmaceuticals to Peers
Other Technical Indicators